leisure time -WSS

leisure time

author：entertainment 2025-09-30 09:29:46 - browse：8141

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Biotech investment managers search for lucrative opportunities

WSS

What Kate Middleton's cancer revelation might teach the world

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

JPM 2024: Nvidia claims we're in biological revolution. Are we?

New menopause drug shows promise in relief for hot flashes

New menopause drug shows promise in relief for hot flashes

Designating disabled people as health disparity population is crucial

hotspot

leisure time

explore

New air purifier tech could be key to improving indoor air quality

Idaho abortion case may prompt more restrictions in other states

Sports medicine is finally prioritizing gender equality

The nurse manager staffing crisis is hurting patients

In Memoriam: Notable people who died in 2023

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Hollywood unions extend contract negotiations for actors

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Hepatitis C has a cure — but many Americans still lack access to it

Three issues to watch in global health in 2024

Wikipedia

Pfizer, Moderna say biotech, pharma drug development is a sprint

'Patient friction coefficient' can gauge a clinical trial's patient burden

As JPM 2024 winds down, some health tech firms project optimism

New menopause drug shows promise in relief for hot flashes

Bring on the sabbaticals for nurses

Caregivers of transplant patients call for more support, training

hotspot

explore

hotspot

Wikipedia